Volume 64, Issue 4, Pages (October 2013)

Slides:

Advertisements

Similar presentations

Early Detection of Prostate Cancer in 2007

Advertisements

Volume 56, Issue 5, Pages (November 2009)

Volume 58, Issue 3, Pages (September 2010)

Volume 55, Issue 1, Pages 1-8 (January 2009)

Prostate cancer mortality in screen and clinically detected prostate cancer: Estimating the screening benefit Pim J. van Leeuwen, David Connolly, Anna.

Volume 70, Issue 3, Pages (September 2016)

The PSA Era is not Over for Prostate Cancer

Volume 54, Issue 2, Pages (August 2008)

Volume 57, Issue 1, Pages (January 2010)

Volume 50, Issue 1, Pages (July 2006)

Volume 52, Issue 1, Pages (July 2007)

Volume 51, Issue 2, Pages (February 2007)

Volume 62, Issue 5, Pages (November 2012)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Testosterone Therapy in Men With Prostate Cancer

Global Trends in Testicular Cancer Incidence and Mortality

Volume 56, Issue 6, Pages (December 2009)

Volume 64, Issue 1, Pages (July 2013)

Systematic Review of the Efficacy and Safety of High-Intensity Focussed Ultrasound for the Primary and Salvage Treatment of Prostate Cancer Marisa Warmuth,

Volume 53, Issue 4, Pages (April 2008)

Volume 64, Issue 6, Pages (December 2013)

Volume 71, Issue 1, Pages (January 2017)

Volume 68, Issue 5, Pages (November 2015)

Volume 73, Issue 6, Pages (June 2018)

Volume 64, Issue 4, Pages (October 2013)

Volume 70, Issue 4, Pages (October 2016)

Let the Games Begin (with EAU Approval)

Volume 61, Issue 2, Pages (February 2012)

Prostate Cancer Epidemic in Sight?

Volume 61, Issue 3, Pages (March 2012)

Volume 63, Issue 4, Pages (April 2013)

Volume 61, Issue 2, Pages (February 2012)

Volume 68, Issue 5, Pages (November 2015)

Volume 54, Issue 4, Pages (October 2008)

Elizabeth K. Bancroft, Rosalind A. Eeles

Prostate Cancer Risk Assessment in Biopsy-naïve Patients: The Rotterdam Prostate Cancer Risk Calculator in Multiparametric Magnetic Resonance Imaging-Transrectal.

Prostate Cancer Detection: A View of the Future

Volume 56, Issue 2, Pages (August 2009)

Low-risk Prostate Cancer: Identification, Management, and Outcomes

Volume 59, Issue 4, Pages (April 2011)

Volume 66, Issue 3, Pages (September 2014)

Volume 66, Issue 6, Pages (December 2014)

Prostate Cancer Epidemic in Sight?

The PSA Era is not Over for Prostate Cancer

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Current Status of Combined Radiation Therapy and Androgen Suppression in Locally Advanced Prostate Cancer: What Is the Way Forward? Michel Bolla European.

Volume 66, Issue 2, Pages (August 2014)

Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia

Volume 71, Issue 1, Pages (January 2017)

Volume 64, Issue 1, Pages (July 2013)

Volume 68, Issue 4, Pages (October 2015)

Is It Necessary to Detect All Prostate Cancers in Men with Serum PSA Levels

Volume 48, Issue 6, Pages (December 2005)

Volume 50, Issue 5, Pages (November 2006)

Volume 58, Issue 3, Pages (September 2010)

Volume 53, Issue 6, Pages (June 2008)

Anna Grenabo Bergdahl, Erik Holmberg, Sue Moss, Jonas Hugosson

CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System

Volume 72, Issue 4, Pages (October 2017)

Testicular Cancer Variations in Time and Space in Europe

Volume 53, Issue 1, Pages (January 2008)

Volume 59, Issue 4, Pages (April 2011)

European Urology is “Your” Journal

Prostate Cancer Screening Decreases the Absolute Risk of Being Diagnosed with Advanced Prostate Cancer—Results from a Prospective, Population-Based Randomized.

Volume 52, Issue 6, Pages (December 2007)

Edith Canby-Hagino, Javier Hernandez, Timothy C. Brand, Ian Thompson

Volume 51, Issue 2, Pages (February 2007)

Volume 54, Issue 3, Pages (September 2008)

Volume 52, Issue 5, Pages (November 2007)

Volume 76, Issue 1, Pages (July 2019)

Presentation transcript:

Volume 64, Issue 4, Pages 530-539 (October 2013) Screening for Prostate Cancer: Results of the Rotterdam Section of the European Randomized Study of Screening for Prostate Cancer Monique J. Roobol, Ries Kranse, Chris H. Bangma, Arno G.J.L.H. van Leenders, Bert G. Blijenberg, Ron H.N. van Schaik, Wim J. Kirkels, Suzie J. Otto, Theo H. van der Kwast, Harry J. de Koning, Fritz H. Schröder European Urology Volume 64, Issue 4, Pages 530-539 (October 2013) DOI: 10.1016/j.eururo.2013.05.030 Copyright © 2013 European Association of Urology Terms and Conditions

Fig. 1 Flow diagram of European Randomized Study of Screening for Prostate Cancer Rotterdam 1993–2010. PCa = prostate cancer; PPV = positive predictive value; CDR = cancer detection rate. * Four men died between invitation and randomization, 221 men were aged 54 yr. ** Four men died between invitation and randomization, 245 men were aged 54 yr. European Urology 2013 64, 530-539DOI: (10.1016/j.eururo.2013.05.030) Copyright © 2013 European Association of Urology Terms and Conditions

Fig. 2 Nelson–Aalen estimates of the cumulative hazard of prostate cancer mortality in men aged (a) 55–74 yr, (b) 55–69 yr, and (c) 70–74 yr at time of randomization. European Urology 2013 64, 530-539DOI: (10.1016/j.eururo.2013.05.030) Copyright © 2013 European Association of Urology Terms and Conditions